Do qTL-based association analyses reveal novel genes influencing pleiotropy of metabolic syndrome ( MetS )?
Using an approach combining genomic, transcriptomic, and bioinformatic data we identified novel candidate genes for MetS.
The addition of WB TLG to clinical data may provide a more detailed prediction of outcome in patients with stage III BC. Moreover, WB MTV and WB TLG are independent factors predicting recurrence of BC. On the contrary, WB SUVmax has poor prognostic significance in this cohort of patients.